Gamma Investing LLC Xenon Pharmaceuticals Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 14 shares of XENE stock, worth $503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 8
75.0%
Holding current value
$503
Previous $268,000
63.43%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
71.1MCall Options Held
361KPut Options Held
288K-
Avoro Capital Advisors LLC New York, NY5.4MShares$194 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$156 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$130 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$129 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$115 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.24B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...